A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR.
Pollin TI, et al.
Science. 2008 Dec 12;322(5908):1702-5. doi: 10.1126/science.1161524.
Science. 2008.
PMID: 19074352
Free PMC article.